Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors
作者:Yong Zhu、Ting Ran、Xin Chen、Jiaqi Niu、Shuang Zhao、Tao Lu、Weifang Tang
DOI:10.1248/cpb.c16-00154
日期:——
A series of 1-(2-aminophenyl)-3-arylurea novel derivatives were synthesized and evaluated against Ephrin type-A receptor 2 (EphA2) and histone deacetylases (HDACs) kinase. Most of the compounds exhibited inhibitory activity against EphA2 and HDAC. The antiproliferative activities were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (thiazolyl blue, tetrazolium blue) against the human cancer cell lines HCT116, K562 and MCF7. Compounds 5a and b showed the most potent inhibitory activity against EphA2 and HDAC. However, compound 5b exhibited higher potency against HCT116 (IC50=5.29 µM) and MCF7 (IC50=7.42 µM). 1-(2-Aminophenyl)-3-arylurea analogues may serve as new EphA2–HDAC dual inhibitors.
研究人员合成了一系列 1-(2-氨基苯基)-3-芳基脲类新型衍生物,并对其针对 Ephrin A 型受体 2(EphA2)和组蛋白去乙酰化酶(HDACs)激酶的活性进行了评估。大多数化合物对 EphA2 和 HDAC 具有抑制活性。用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑(MTT)(噻唑蓝,四唑蓝)对人类癌细胞株 HCT116、K562 和 MCF7 的抗增殖活性进行了评估。化合物 5a 和 b 对 EphA2 和 HDAC 的抑制活性最强。然而,化合物 5b 对 HCT116(IC50=5.29 µM)和 MCF7(IC50=7.42 µM)表现出更高的效力。1-(2-Aminophenyl)-3-arylurea 类似物可作为新的 EphA2-HDAC 双重抑制剂。